Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia

doi:10.4239/wjd.v16.i9.106002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

This Article

(48)

(40)

(0)

(983)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Sep 15, 2025; 16(9): 106002
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.106002

Table 3 Summary of the statistical significance of the variables associated with hypofiltration, showing the P values and false discovery rate-adjusted values

Variables	P value	FDR
TNF-R1	6.65 × 10^-6	0.00044
TNF-R2	0.00015	0.0046
TIM-3	0.0006	0.012
Gal3	0.01
Age	0.02
IL-6	0.04
LDL	0.045

FDR: False discovery rate; IL-6: Interleukin-6; TIM-3: T-cell immunoglobulin and mucin domain 3; TNF-R2: Tumor necrosis factor receptor 2; Gal3: Galectin-3; TNF-R1: Tumor necrosis factor receptor 1; LDL: Low-density lipoprotein. Bonferroni threshold for our study is P > 0.0007.

Full Size Table

Citation: Mas-Fontao S, Civantos E, Boukichou-Abdelkader N, Moreno JA, Gomez-Guerrero C, Gálvez MIL, Tuomilehto J, Lind M, Gabriel R, Egido J. Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia. World J Diabetes 2025; 16(9): 106002
URL: https://www.wjgnet.com/1948-9358/full/v16/i9/106002.htm
DOI: https://dx.doi.org/10.4239/wjd.v16.i9.106002

Mas-Fontao S, Civantos E, Boukichou-Abdelkader N, Moreno JA, Gomez-Guerrero C, Gálvez MIL, Tuomilehto J, Lind M, Gabriel R, Egido J. Increased tumor necrosis factor-receptor superfamily plasma levels are associated with early renal or retinal involvement in intermediate hyperglycemia. World J Diabetes 2025; 16(9): 106002 [PMID: 40980291 DOI: 10.4239/wjd.v16.i9.106002]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.